Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioSpecifics Technologies Corp. Announces Initiation Of Phase IIb Trial For Peyronie's Disease
BioSpecifics Technologies Corp. Announces Initiation Of Phase IIb Trial For Peyronie's Disease
BioSpecifics Technologies Corp. Announces Initiation Of Phase IIb Trial For Peyronie's Disease
Submitted by
admin
on September 20, 2008 - 11:53am
Source:
Medical News Today
Headline:
BioSpecifics Technologies Corp. Announces Initiation Of Phase IIb Trial For Peyronie's Disease
Do Not Allow Advertisers to Use My Personal information
